)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Elicera Therapeutics (ELIC) investor relations material
Elicera Therapeutics Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary14 Nov, 2025
Executive summary
Achieved operating profit of SEK 146,689 in Q3 2025, a significant improvement from SEK -2,697,267 in Q3 2024, driven by increased grant income and higher costs.
Loss for the period narrowed to SEK -10,441,379 for Jan–Sep 2025 from SEK -13,507,085 year-over-year.
Key clinical progress in CARMA study: 4 of 6 patients at lowest dose showed complete metabolic response, with no serious adverse events.
ELC-100 received Orphan Drug Designation in the U.S. for pancreatic neuroendocrine tumors.
Raised SEK 22.0 million through new share subscription and directed issue.
Financial highlights
Q3 2025 operating profit: SEK 146,689 (Q3 2024: SEK -2,697,267); Jan–Sep 2025 operating loss: SEK -10,815,056 (Jan–Sep 2024: SEK -13,972,098).
Earnings per share for Q3 2025: SEK +0.01 (Q3 2024: SEK -0.07); Jan–Sep 2025: SEK -0.23 (Jan–Sep 2024: SEK -0.45).
Cash flow from operating activities for Jan–Sep 2025: SEK -11,474,233 (Jan–Sep 2024: SEK -19,231,075).
Cash and cash equivalents at period end: SEK 34,923,463 (Sep 2024: SEK 30,631,198).
Outlook and guidance
CARMA study continues with patient recruitment in the highest dose cohort; preliminary data from this group expected in spring 2026.
Final reporting of ELC-100 Phase I/II study postponed to turn of 2025/2026 due to database transition.
Ongoing efforts to secure soft funding and partnerships for preclinical programs, especially ELC-401 for glioblastoma.
ELC-301 licensing strategy post-CARMA data
ELC-100 study delay: impact on commercialization?
iTANK platform: new application areas via collaborations?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Elicera Therapeutics earnings date
Q4 202513 Feb, 2026
Next Elicera Therapeutics earnings date
Q4 202513 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Elicera Therapeutics AB is a Sweden-based clinical-stage immuno-oncology company. The company focuses on developing next-generation cell and gene therapies aimed at treating cancer through immune-based approaches. Elicera's pipeline includes four main drug candidates, two of which are in the field of oncolytic viruses and two in CAR T-cell therapies. Their proprietary iTANK (ImmunoTherapies Activated with Nap for efficient Killing) platform is designed to enhance the efficacy of these therapies. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage